Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2025-12-25 @ 3:55 AM
NCT ID:
NCT04934202
Eligibility Criteria:
For the 6-month evaluation of patients from the 2nd epidemic wave
* Inclusion criteria
* Age ≥18 years old
* COVID-19 defined either by a reverse transcriptase-polymerase chain reaction (RT-PCR) or by a combination of clinical signs and compatible lung CT scan
* Hospitalization for COVID-19 after 1st July 2020
* Living out of the hospital
* Exclusion criteria
* Death occurring between index hospitalization and reassessment
* Patient refusal
* Discovery of a positive RT-PCR for SARS-CoV-2 during hospitalization for a reason other than COVID-19
* Nosocomial COVID-19
For the 12-month evaluation of patients from the 1st epidemic wave
* Inclusion criteria
◌ Presence of general, cognitive, psychological and respiratory symptoms during the assessment made at 4 months in COMEBAC "1st wave"
* Exclusion criteria
* Death occurring between the evaluation in COMEBAC "1st wave" and the re-evaluation
* Patient refusal
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04934202
Study Brief:
Protocol Section:
NCT04934202